Velineni Sridhar, Schiltz Paul, Chang Ko-Hsin, Peng Yi-Ming, Cowles Bobby
Veterinary Medicine Research and Development, Zoetis, Kalamazoo, MI, United States.
Associate Professor and Director of Equine Studies, William Woods University, Fulton, MO, United States.
Front Vet Sci. 2024 Oct 10;11:1436714. doi: 10.3389/fvets.2024.1436714. eCollection 2024.
Abnormal blood glucose (BG) levels often seen in critically ill horses are significantly associated with adverse patient outcomes and increased mortality. Rapid and accurate BG monitoring is now considered an essential component of evidence-based equine practice and can provide critical information quickly for treatment. Although several point-of-care (POC) BG monitoring hand-held devices are commercially available for veterinary use, none contains a unique algorithm validated for use in horses. The AlphaTrak 3 (AT3) BG monitoring system is a first-of-its-kind device with an equine-specific algorithm that allows stall-side clinical decision making, and frequent monitoring at minimal cost. As such, AT3 is potentially a preferred alternative to more costly and time-consuming standard diagnostic reference laboratory methods. The objective of this study was to determine the accuracy of the AT3 device in measuring BG levels in equine whole blood samples in comparison to results obtained by the Beckman Coulter AU480 reference analyzer per ISO15197:2013 specifications. Accuracy of the AT3 equine algorithm were initially verified by testing equine blood samples with artificially adjusted blood glucose levels followed by its validation in a field study. Testing with artificially adjusted equine samples ( = 129) showed that 98.9% of glucose measurements ranging from 29 to 479 mg/dL fell within ISO accuracy threshold of ±15 mg/dL or ±15% of the average reference value. In addition, 100% of the AT3 measurements fell in consensus error grid (CEG) zone A, which indicates that test outcomes have a minimal likelihood of adverse clinical impact. In a follow-up field study involving 96 horses, 98.4% of AT3 measurements met the ISO accuracy threshold and 99.2% of AT3 measurements fell in CEG zone A. These results demonstrate that the AT3 glucometer has a high degree of accuracy in horses and is a dependable, convenient, and cost-effective device for accurately monitoring equine BG levels in farm or clinical settings.
危重病马中常见的血糖(BG)水平异常与不良的患者预后及死亡率增加显著相关。快速准确的BG监测现已被视为循证马医学实践的重要组成部分,并且能够迅速提供关键信息以指导治疗。尽管有几种即时检验(POC)BG监测手持式设备已在市场上供兽医使用,但没有一种包含经过验证可用于马匹的独特算法。AlphaTrak 3(AT3)BG监测系统是首款具有马专用算法的设备,可在马厩旁进行临床决策,并以最低成本进行频繁监测。因此,与成本更高且耗时的标准诊断参考实验室方法相比,AT3可能是一种更优选择。本研究的目的是根据ISO15197:2013规范,将AT3设备测量马全血样本中BG水平的准确性与贝克曼库尔特AU480参考分析仪获得的结果进行比较。AT3马用算法的准确性首先通过检测人工调整血糖水平的马血样本进行验证,随后在一项现场研究中进行验证。对人工调整的马样本(n = 129)进行检测表明,98.9%的血糖测量值在29至479 mg/dL范围内,落在ISO精度阈值±15 mg/dL或平均参考值的±15%之内。此外,100%的AT3测量值落在一致性误差网格(CEG)A区,这表明测试结果对临床产生不良影响的可能性极小。在一项涉及96匹马的后续现场研究中,98.4%的AT3测量值符合ISO精度阈值,99.2%的AT3测量值落在CEG A区。这些结果表明,AT3血糖仪在马匹中具有高度准确性,是一种可靠、便捷且经济高效的设备,可用于在农场或临床环境中准确监测马的BG水平。